Upstream Bioprocessing Market Is Set to Hit $12.60 Billion By 2026: Grand View Research, Inc

 Breaking News
  • No posts were found

Upstream Bioprocessing Market Is Set to Hit $12.60 Billion By 2026: Grand View Research, Inc

Upstream Bioprocessing Market Is Set to Hit $12.60 Billion By 2026: Grand View Research, Inc

Grand View Research, Inc. – Market Research And Consulting.
According to report published by Grand View Research, The global upstream bioprocessing market size was estimated at USD 4.77 billion in 2018 and is expected to register a CAGR of 12.90% over the forecast period.

The global upstream bioprocessing market size is expected to reach USD 12.60 billion by 2026, expanding at a CAGR of 12.90% during the forecast period, according to a new report by Grand View Research, Inc. Commercial success and wide acceptance of biopharmaceuticals have provided lucrative growth avenues to several in house as well as contract manufacturing biopharmaceutical companies. Furthermore, a confluence of factors, such as high demand for biosimilars and biologics, launch of improved cost-effective technologies, and growing acceptance of single-use systems have driven the revenue performance of the market.

Start-ups and new market entrants often face budget constraints while establishing new biomanufacturing plants. Thus, these entities expand their biotherapeutics portfolio by outsourcing the production process to contract services, thereby aiding in revenue growth for upstream bioprocessing services.

Continuous upstream bioprocessing has greatly benefited the bioprocessing industry. Rising implementation of methods, such as acoustic wave technology and continuous centrifugation, for clarification of bioreactor cultures tends to minimize the clarification burden. This, in turn, increases the cell-culture densities, consequently resulting in efficient upstream processes.

Ongoing advancements in cell line productivity with respect to protein expression and clone screening are expected to result in the fastest CAGR of cell culture products over the forecast period. Cell culture is considered as the most challenging and crucial step in upstream bioprocessing, and thus demands more attention with respect to technological intricacies, resulting in the largest share in the upstream bioprocessing market.

Factors such as multi-use systems incur one-time investment, are applicable for larger bioprocessing volumes and maintain the pH and oxygen accurately resulting in high usage rate of these systems. However, a paradigm shift from conventional stainless-steel bioreactors to single-use bioreactor systems has attributed to the lucrative growth of the single-use segment.

Key market players are adopting strategic initiatives, such as novel product developments, mutually beneficial partnerships, agreements, and geographical expansion to reinforce their market presence. For instance, in February 2019, Danaher Corporation signed an agreement to acquire the Biopharma business of GE Life Sciences. The acquisition broadened Danaher’s market presence with the addition of GE Biopharma’s cell culture media, single-use technologies, development instrumentation, and consumables to its existing portfolio.

Browse Details of Report, Please Visit @

France upstream bioprocessing market size, by workflow, 2015 - 2026 (USD Million)

Key Takeaways from the report:

  • High availability of bioreactors and continuous launches of single-use bioreactors by the key market players can be attributed to the remarkable revenue share of the bioreactors segment
  • Presence of well-established biopharmaceutical manufacturing firms capable of performing in-house bioproduction has led to the maximum revenue share of this segment
  • Outsourced mode of upstream bioprocessing is anticipated to witness the fastest CAGR over the forecast period, owing to increase in investments and expansion of manufacturing capabilities through the integration of single-use systems in the plants by CMOs
  • North America dominated the global upstream bioprocessing market as a result of the continuous innovations in biotechnology and rising preferences for biopharmaceuticals in the region. Moreover, the presence of substantial in-house biopharmaceutical manufacturers coupled with numerous investments in the U.S. biologics market has driven the growth
  • Asia Pacific is poised to witness the fastest CAGR over the forecast period due to growing awareness about the rapid analytical methods that can be used for in-process control during the upstream workflows

Global upstream bioprocessing market share, by mode, 2018 (%)

Have Any Query? Ask Our Experts @

Grand View Research has segmented the global upstream bioprocessing market report on the basis of product, workflow, use type, mode, and region:

Upstream Bioprocessing Product Outlook (Revenue, USD Million, 2015 – 2026)

  • Bioreactors/Fermenters
  • Cell Culture Products
  • Filters
  • Bioreactors Accessories
  • Bags & Containers
  • Others

Upstream Bioprocessing Workflow Outlook (Revenue, USD Million, 2015 – 2026)

  • Media Preparation
  • Cell Culture
  • Cell Separation

Upstream Bioprocessing Use Type Outlook (Revenue, USD Million, 2015 – 2026)

  • Multi Use
  • Single Use

Upstream Bioprocessing Mode Outlook (Revenue, USD Million, 2015 – 2026)

  • In-house
  • Outsourced

Upstream Bioprocessing Regional Outlook (Revenue, USD Million, 2015 – 2026)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
  • Asia Pacific
    • China
    • India
  • Latin America
    • Brazil
  • Middle East and Africa (MEA)
    • South Africa

Browse Related Reports :

Downstream Processing Market Size, Share & Trends Analysis Report By Application (Antibodies, Antibiotic Production), By Product (Filters, Evaporators), By Technique, And Segment Forecasts, 2018 – 2025

Viral Vector & Plasmid DNA Manufacturing Market Analysis Report By Application, By Disease (Cancer, Genetic), By Workflow (Upstream, Downstream), By Vector, By End Use, And Segment Forecasts, 2019 – 2025

About Grand View Research

Grand View Research provides syndicated as well as customized research reports and consulting services on 46 industries across 25 major countries worldwide. This U.S.-based market research and consulting company is registered in California and headquartered in San Francisco. Comprising over 425 analysts and consultants, the company adds 1200+ market research reports to its extensive database each year. Supported by an interactive market intelligence platform, the team at Grand View Research guides Fortune 500 companies and prominent academic institutes in comprehending the global and regional business environment and carefully identifying future opportunities.


Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1-415-349-0058, Toll Free: 1-888-202-9519
Address:201, Spear Street, 1100
City: San Francisco
State: California
Country: United States